首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Structure of the deacetylase LpxC bound to the antibiotic CHIR-090: Time-dependent inhibition and specificity in ligand binding
【24h】

Structure of the deacetylase LpxC bound to the antibiotic CHIR-090: Time-dependent inhibition and specificity in ligand binding

机译:脱乙酰基酶LpxC与抗生素CHIR-090结合的结构:时间依赖性抑制和配体结合特异性

获取原文
获取原文并翻译 | 示例
       

摘要

The UDP-3-O-(R-3-hydroxyacyl)-N-acetylglucosamine deacetylase LpxC is an essential enzyme of lipid A biosynthesis in Gram-negative bacteria and a promising antibiotic target. CHIR-090, the most potent LpxC inhibitor discovered to date, displays two-step time-dependent inhibition and kills a wide range of Gram-negative pathogens as effectively as ciprofloxacin or tobramycin. In this study, we report the solution structure of the LpxC-CHIR-090 complex. CHIR-090 exploits conserved features of LpxC that are critical for catalysis, including the hydrophobic passage and essential active-site residues. CHIR-090 is adjacent to, but does not occupy, the UDP-binding pocket of LpxC, suggesting that a fragment-based approach may facilitate further optimization of LpxC inhibitors. Additionally, we identified key residues in the Insert II hydrophobic passage that modulate time-dependent inhibition and CHIR-090 resistance. CHIR-090 shares a similar, although previously unrecognized, chemical scaffold with other small-molecule antibiotics such as L-161,240 targeting LpxC, and provides a template for understanding the binding mode of these inhibitors. Consistent with this model, we provide evidence that L-161,240 also occupies the hydrophobic passage.
机译:UDP-3-O-(R-3-羟酰基)-N-乙酰氨基葡糖脱乙酰基酶LpxC是革兰氏阴性细菌中脂质A生物合成的必需酶,也是有希望的抗生素靶标。 CHIR-090是迄今发现的最有效的LpxC抑制剂,具有两步时间依赖性抑制作用,可以杀死环丙沙星或妥布霉素等多种革兰氏阴性病原体。在这项研究中,我们报告了LpxC-CHIR-090复合体的解决方案结构。 CHIR-090利用LpxC的保守特性对催化至关重要,包括疏水通道和基本的活性位点残基。 CHIR-090与LpxC的UDP绑定袋相邻但不占据,这表明基于片段的方法可能有助于进一步优化LpxC抑制剂。此外,我们在插入片段II疏水通道中发现了关键残基,这些残基可调节时间依赖性抑制和CHIR-090抗性。 CHIR-090与其他小分子抗生素(例如靶向LpxC的L-161,240)共享相似的化学支架(尽管以前未被认可),并为了解这些抑制剂的结合方式提供了模板。与该模型一致,我们提供了L-161,240也占据疏水通道的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号